Treatment with GM1 ganglioside reverses dopamine D-2 receptor supersensitivity induced by the neurotoxin MPTP
- 1 September 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 168 (2) , 261-264
- https://doi.org/10.1016/0014-2999(89)90575-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical studyBrain Research, 1989
- Treatment with GM1 Ganglioside Restores Striatal Dopamine in the 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Treated MouseJournal of Neurochemistry, 1988
- Administration of GM1 ganglioside eliminates neuroleptic-induced sensorimotor deficits in MPTP-treated miceNeuroscience Letters, 1988
- Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeysNeuroscience Letters, 1988
- Acute stress or neuroleptics elicit sensorimotor deficits in MPTP-treated miceNeuroscience Letters, 1988
- Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmissionNeuroscience Letters, 1988
- Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor densityBrain Research, 1986
- Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor systemBrain Research, 1986
- Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatmentNeuroscience Letters, 1983